What is RICH

RICH is an initiative that has been conceived to unlock the national treasure created by the top scientific research institutions in Telangana State, and to actively facilitate the process of taking their research to market. This requires new ideas, innovations, technologies, advisors, mentors, funding and support services, to be brought together seamlessly. The Government recognizes that there are gaps in this innovation-entrepreneurship-investment ecosystem, which has prevented full utilization of the R&D work taking place in these institutions. RICH is the platform that will link research institutions, academia and industry along with venture capitalists, angel investors and incubators. RICH will initially focus on three sectors, same model of collaboration will later be extended to other priority sectors of the State.

Youtube Video



Research & Academic
Institutions Onboarded


Business Alliances




Technologies Listed
available for licensing


Startups & Entrepreneurs


Equipment Listed


Activities of RICH

Introduce entrepreneurs to investors and funders for various stages of their growth, thus helping raise funds

Provide IP protection for the innovations emerging from the research, and create mechanisms for licensing the IP.

Coordinate training inputs in design thinking, business management & project execution for scientists & entrepreneurs.

Help entrepreneurs and businesses conduct initial evaluations of the feasibility of taking their innovations to market.

Bringing the best of technical, legal, economic, and market assessments for the companies and startups.

Introduce entrepreneurs to investors and funders for various stages of their growth. Thus helping raise funds

Provide policy inputs to the government for creating an innovation-led entrepreneurial culture in the State.

Support educational institutions to ensure practical training for technical graduates, making them employable once out of college.

News & Events

AID is back! Calling all Healthcare Start Ups

RICH announces the launch of Cohort 2 of its Acceleration Initiative for Diagnostics (AID) program to help diagnostic start-ups reach